Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis

Genes and Development

Volumn 13, Issue 4, 1999, Pages 400-411

  Grumont, Raelene J ^a   Rourke, Ian J ^a   Gerondakis, Steve ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

A1; Apoptosis; Lymphocyte; Mitogenesis; Rel NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENE;

EID: 0033557805     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.4.400     Document Type: Article

References (59)

1. Abbadie, C., N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Vandenbunder, and P.J. Enrietto. 1993. High levels of c-rel expression arc associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75: 899-912.
2. Adams, J.M. and S. Cory. 1998. The bcl-2 protein family: Arbiters of cell survival. Science 281: 1322-1326.
3. Adams, J.M., A.W. Harris, C.A. Pinkert, L.M. Corcoran, W.S. Alexander, S. Cory, R.B. Palmiter, and R.L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538.
4. Baeuerle, P.A. and D. Baltimore. 1996. NF-kappa B: Ten years after. Cell 87: 13-20.
5. Baeuerle, P.A. and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12: 141-179.
6. Baldwin, A.S. Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649-683.
7. Beg, A.A. and D. Baltimore. 1996. An essential role for NF-kappa B in preventing TNF-alpha-induced cell death. Science 274: 782-784.
8. Boehmelt, G., A. Walker, N. Kabrun, G. Mellitzer, H. Beug, M. Zenke, and P.J. Enrietto. 1992. Hormone-regulated v-rel estrogen receptor fusion protein: Reversible induction of cell transformation and cellular gene expression. EMBO J. 11: 4641-4652.
9. Boehmelt, G., J. Madruga, P. Dorfler, K. Briegel, H. Schwarz, P.J. Enrietto, and M. Zenke. 1995. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell 80: 341-352.
10. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
11. Capobianco, A.J. and T.D. Gilmore. 1993. A conditional mutant of vRel containing sequences from the human estrogen receptor. Virology 193: 160-170.
12. Choi, S.S., I.C. Park, J.W. Yun, Y.C. Sung, S.I. Hong, and H.S. Shin. 1995. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698.
13. Chu, Z.L., T.A. McKinsey, L. Liu, J.J. Gentry, M.H. Malim, and D.W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-iap2 is under NF-κB control. Proc. Natl. Acad. Sci. 94: 10057-10062.
14. Conradt, B. and H.R. Horvitz. 1998. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93: 519-529.
15. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13: 513-543.
16. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16: 1295-1304.
17. Finco, T.S. and A.S. Baldwin. 1995. Mechanistic aspects of NF-kappa B regulation: The emerging role of phosphorylation and proteolysis. Immunity 3: 263-272.
18. Gerondakis, S., R. Grumont, I. Rourke, and M. Grossman. 1998. The regulation and roles of Rel/NκB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10: 353-359.
19. Green, D.R. and J.C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
20. Grigoriadis, G., Y. Zhan, R.J. Grumont, D. Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: Distinct roles for Rel in different macrophage populations. EMBO J. 15: 7099-7107.
21. Grumont, R.J. and S. Gerondakis. 1990. The murine c-rel protooncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli. Oncogene Res. 5: 245-254.
22. _. 1994. The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ. 5: 1321-1331.
23. Grumont, R.J., I.B. Richardson, C. Gaff, and S. Gerondakis. 1993. rel/NF-kappa B nuclear complexes that bind KB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells. Cell Growth Differ. 4: 731-743.
24. Grumont, R.J., I.J. Rourke, L.A. O'Reilly, A. Strasser, K. Miyake, W. Sha, and S. Gerondakis. 1998. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187: 663-674.
25. Hengartner, M.O. and H.R. Horvitz. 1994. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 4: 581-586.
26. Herschman, H.R. 1991. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60: 281-319.
27. Ho, S.N., H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
28. Huang, D.C., S. Cory, and A. Strasser. 1997a. Bcl-2, Bcl-XL and adenovirus protein ElB19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14: 405-414.
29. Huang, D.C., L.A. O'Reilly, A. Strasser, and S. Cory. 1997b. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16: 4628-4638.
30. Karsan, A., E. Yee, K. Kaushansky, and J.M. Harlan. 1996. Cloning of human Bcl-2 homologue: Inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87: 3089-3096.
31. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes & Dev. 9: 1965-1977.
32. Lin, E.Y., A. Orlofsky, M.S. Berger, and M.B. Prystowsky. 1993. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151: 1979-1988.
33. Lin, E.Y., A. Orlofsky, H.G. Wang, J.C. Reed, and M.B. Prystowsky. 1996. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87: 983-992.
34. Liu, Z.G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565-576.
35. Luckow, B. and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15: 5490.
36. Miyake, K., Y. Yamashita, Y. Hitoshi, K. Takatsu, and M. Kimoto. 1994. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: Unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med.180: 1217-1224.
37. Osmond, D.G. 1993. The turnover of B-cell populations. Immunol. Today 14: 34-37.
38. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. 90: 8392-8396.
39. Piechaczyk, M., J.M. Blanchard, L. Marty, C. Dani, F. Panabieres, S. El Sabouty, P. Fort, and P. Jeanteur. 1984. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res. 12: 6951-6963.
40. Pike, B.L., M.R. Alderson, and G.J. Nossal. 1987. T-independent activation of single B cells: An orderly analysis of overlapping stages in the activation pathway. Immunol. Rev. 99: 119-152.
41. Pohlman, T.H. and J.M. Harlan. 1989. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell. Immunol. 119: 41-52.
42. Raff, M.C. 1992. Social controls on cell survival and cell death. Nature 356: 397-400.
43. Riddle, V.G., R. Dubrow, and A.B. Pardee. 1979. Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cells. Proc. Natl. Acad. Sci. 76: 1298-1302.
44. Schwartz, L.M. and B.A. Osborne. 1993. Programmed cell death, apoptosis and killer genes. Immunol. Today 14: 582-590.
45. Schwartz, R.C. and O.N. Witte. 1988. A recombinant murine retrovirus expressing v-rel is cytopathic. Virology 165: 182-190.
46. Sha, W.C., H.C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80: 321-330.
47. Sonenshein, G.E. 1997. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8: 113-119.
48. Stehlik, C., R. de Martin, I. Kumabashiri, J.A. Schmid, B.R. Binder, and J. Lipp. 1998. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor a-induced apoptosis. J. Exp. Med. 188: 211-216.
49. Strasser, A. 1995. Life and death during lymphocyte development and function: Evidence for two distinct killing mechanisms. Curr. Opin. Immunol. 7: 228-234.
50. Thornberry, N.A. and Y. Lazebnik. 1998. Caspases: Enemies within. Science 281: 1312-1316.
51. Tomayko, M.M. and M.P. Cancro. 1998. Long-lived B cells are distinguished by elevated expression of A1. J. Immunol. 160: 107-111.
52. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 787-789.
53. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes & Dev. 9: 2723-2735.
54. Wang, C.Y., M.W. Mayo, and A.S. Baldwin Jr. 1996. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274: 784-787.
55. Wang, C.Y., M.W. Mayo, R.G. Kornuluk, D.V. Goeddel, and A.S. Baldwin Jr. 1998. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
56. Wu, M.X., Z. Ao, K.V. Prasad, R. Wu, and S.F. Schlossman. 1998. IEX-IL, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281: 998-1001.
57. Wyllie, A.H., J.F. Kerr, and A.R. Currie. 1980. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
58. You, M., P-T. Ku, R. Hrdlickova, and H.R. Bose Jr. 1997. chIAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol. Cell. Biol. 17: 7328-73541.
59. Zurovec, M., O. Petrenko, R. Roll, and P.J. Enrietto. 1998. A chicken c-rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation. Oncogene 16: 3133-3142.